• Aucun résultat trouvé

3CN PEPTIDES

N/A
N/A
Protected

Academic year: 2022

Partager "3CN PEPTIDES"

Copied!
1
0
0

Texte intégral

(1)

N N

°'

U1 Ln

"'

"'

"'

<(

V) w

~

N N

°'

U1 Ln

"'

"'

"'

<(

"-

u

"'

"'

0 r;;

0

~ E

m C 0

<D

~

a,

"O

3CN PEPTIDES

Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM) 143-147 bd Anatole France FR-93285 Saint Denis Cedex France

Copy to Regulatory Affairs Welding GmbH & Co. KG

Ref: Letter of Access to ASMF for Teriparatide (eCTD-PTH).

Number of Active Substance Master File: unknown Name of Active Substance: Teriparatide

29th January 2019

Active Substance Master File holder: BCN Peptides S.A. [Address: Pol. Ind. Eis Vinyets-Els Fogars II, 08777, Sant Quintf de Mediona, Barcelona (Spain)]

To whom it may concern:

The aforementioned Active Substance Master File holder hereby authorises the Agence Nationale de Securite du Medicament et des Produits de Sante to refer to and review the above mentioned Active Substance Master File in support of the following Marketing Authorisation Application(s) or Marketing Authorisation Variation(s) submitted by Welding GmbH & Co. KG:

• Products:

Teriparatide 20 µg/ 80µ1 Solution for injection in pre-filled pen (DE/H/6160/001/DC)

Marketing Authorisation Holder: Welding GmbH & Co. KG, [Esplanade 39, 20354 Hamburg, Germany]

The aforementioned Active Substance Master File holder commits to ensure batch to batch consistency and to inform Welding GmbH & Co. KG, and Competent Authority of any change in the Active Substance Master File likely to alter in any way the quality and/or safety of products.

The aforementioned Active Substance Master File holder hereby is informed of and accepts that the EEA National Competent Authorities, the EMA including all CHMP and CVMP Members and their experts, and the Certification of Substances Division of the European Directorate for the Quality of Medicines & Healthcare may share the assessment reports of the above mentioned Active Substance Master File amongst themselves.

Please be so kind as to acknowledge receipt.

Sincere}v yoll{s.

Silvia~

Regulatory Affairs BCN Peptides S.A.

Pol. Ind. Eis Vinyets-Els Fogars, II

08777, Sant Quintf de Mediona, Barcelona (Spain) sarrastia@bcnpeptides.com

www.bcnpeptides.com . Tel. +34 938 191 399 . Fax +34 938 264 909 . Pol. Ind. Eis V1nyets-Els Fogars II . 08777 Sant Ouinti de Mediona lBarcelonaJ · SPAIN

Références

Documents relatifs

Dans le cadre de cette restructuration, Evil Corp a commencé à distribuer une nouvelle variante de ransomware appelée WastedLocker lors d'attaques ciblées contre les

The aforementioned Active Substance Master File holder hereby authorizes the French National Agency for Medicines and Health Products Safety/France to refer to and review

The aforementioned Active Substance Master File holder hereby authorises the National Agency for the Saf ety of Medicine and Health Products I France to refer to

The aforementioned Active Substance Master File holder hereby authorizes the ANSM, to refer to and review the above mentioned Active Substance Master File in support

The aforementioned Active Substance Master File holder commits to ensure batch to batch consistency and to inform Pharmathen and concerned health authorities any changes

All documents relative to an ASMF to be sent only via CESP and at least one month before the submission of Marketing Authorization Application or Marketing Authorization Variation

 Enclose a copy of the Submission Letter and Administrative Details for documents relating to an Active Substance Master File (ASMF) (Annex 3 of the European Guideline on

Le Plan Général de coordination en matière de Sécurité et de Protection de la Santé (P.G.C.S.P.S.) qui vous est communiqué sur le site WEB dans le «